News
RELIEF THERAPEUTICS Holding SA Announces Results of Annual General Meeting
RELIEF THERAPEUTICS Holding SA Announces Results of Annual General Meeting
Kuros Biosciences Announces Peer-Reviewed Publication of MagnetOs MAXA Level 1 Study Outcomes in Spine, Indicating Superiority Over Autograft
Kuros Biosciences Announces Peer-Reviewed Publication of MagnetOs MAXA Level 1 Study Outcomes in Spine, Indicating Superiority Over Autograft
EGS Beteiligungen AG exercises right to convert bond and increases its shareholding in Siegfried to 6.2% registered shares
EGS Beteiligungen AG exercises right to convert bond and increases its shareholding in Siegfried to 6.2% registered shares
Siegfried to acquire an early-phase CDMO in Wisconsin (US) to strengthen its Drug Substances service offering
Siegfried to acquire an early-phase CDMO in Wisconsin (US) to strengthen its Drug Substances service offering
Annual General Shareholders’ Meeting 2024: Sonova shareholders approve all motions of the Board of Directors
Annual General Shareholders’ Meeting 2024:
Sonova shareholders approve all motions of the Board of Directors
Relief Therapeutics Announces Notice of Annual General Meeting of Shareholders
Relief Therapeutics Announces Notice of Annual General Meeting of Shareholders
Edison issues review on BB Biotech (BION): A recovering sector with a healthy prognosis
Edison issues review on BB Biotech (BION): A recovering sector with a healthy prognosis
Q1 2024 Qualitative Update: Performance In Line with Expectations for Full-Year 2024
Q1 2024 Qualitative Update: Performance In Line with Expectations for Full-Year 2024
Financial year 2023/24: Sonova ends year on improving trajectory after growth picks up in second half
Financial year 2023/24: Sonova ends year on improving trajectory after growth picks up in second half
Lonza Announces Results of the 2024 Annual General Meeting – All Motions Proposed by Board of Directors Approved
Lonza Announces Results of the 2024 Annual General Meeting – All Motions Proposed by Board of Directors Approved
Relief Therapeutics Announces New Executive Leadership Team strengthening capabilities to guide the Company through pipeline development initiatives
Relief Therapeutics Announces New Executive Leadership Team strengthening capabilities to guide the Company through pipeline development initiatives
Relief Therapeutics has published its Annual Report
Relief Therapeutics has published its Annual Report
RELIEF THERAPEUTICS Holding SA Announces Results of Extraordinary General Meeting
RELIEF THERAPEUTICS Holding SA Announces Results of Extraordinary General Meeting
EQS-Adhoc: BB Biotech AG publishes its interim report
EQS-Adhoc: BB Biotech AG publishes its interim report
EQS-News: BB Biotech presents solid first-quarter results; biotech stock market impacted by shifting views on interest rates
EQS-News: BB Biotech presents solid first-quarter results; biotech stock market impacted by shifting views on interest rates
Kuros reports Corporate Highlights as of Q1 2024 including increase in direct MagnetOsTM sales
Kuros reports Corporate Highlights as of Q1 2024 including increase in direct MagnetOsTM sales
Lonza Prices EUR 1 Billion Straight Bond with a 3.875% Coupon
Lonza Prices EUR 1 Billion Straight Bond with a 3.875% Coupon
Annual General Meeting of Kuros Biosciences approves all resolutions
Annual General Meeting of Kuros Biosciences approves all resolutions
Shareholders of Evolva Holding SA in liquidation approve BoD proposals at AGM; revocation of liquidation and delisting also approved whereas introduction of opting-out was rejected
Shareholders of Evolva Holding SA in liquidation approve BoD proposals at AGM; revocation of liquidation and delisting also approved whereas introduction of opting-out was rejected
Lonza Publishes Invitation to the 2024 Annual General Meeting and 2023 Annual and Sustainability Reports
Lonza Publishes Invitation to the 2024 Annual General Meeting and 2023 Annual and Sustainability Reports
Lonza Appoints Wolfgang Wienand as New Chief Executive Officer
Lonza Appoints Wolfgang Wienand as New Chief Executive Officer
RELIEF THERAPEUTICS Holding SA to Hold Extraordinary General Meeting
RELIEF THERAPEUTICS Holding SA to Hold Extraordinary General Meeting